PubMed Health⌕ Search

Biomedical subjects

S Hamaji

Publications and source records attributed to S Hamaji.

2 recordsLinked to original sources

Inter-isoformal regulation of nitric oxide synthase through heteromeric dimerization.

Biochemical characterization of neuronal nitric oxide synthase (nNOS) has demonstrated a unique complexity with the native protein being a homodimer. To cast light on its enzyme structure-activity relationship, inactive nNOS, generated by mutation of (Lys732-Lys-Leu) to (Asp732-Asp-Glu) (Watanabe et al., FEBS Lett., 403 (1997) 75-78), and active nNOS were co-expressed using the Sf9 and COS-7 cell expression system. Co-transfectants of active and inactive nNOS resulted in attenuation of Ca2+/calmodulin (CaM) dependent NOS enzyme activity to a level 46.4+/-4.30% as much as active homomeric enzyme. Dimerization between active and inactive nNOS was observed by low temperature SDS-PAGE in the co-transfectants. The dimerization and attenuation of Ca2+/CaM dependent activity were not observed when active and inactive nNOS were combined in vitro, indicating that nNOS dimerization occurs intracellularly to form an active enzyme. Furthermore, we co-expressed inactive nNOS with active inducible NOS (iNOS) to analyze inter-isoformal regulation of NOSs. Interestingly, inactive nNOS also showed similar effects on enzyme activity and heteromeric dimerization against iNOS, thus indicating that inter-isoformal regulation of the two isoforms might also be involved in control of neuron function.

Animals↗

Neuronal nitric oxide synthase-membrane phospholipid interactions.

Most of the neuronal nitric oxide synthase (nNOS) is present in the particulate fraction of tissue extracts. Here, we show that the calmodulin (CaM)-binding domain of nNOS interacts with anionic phospholipid vesicles but not with neutral ones. Identification of residues in the CaM-binding domain of nNOS as the key domain for the interaction is also documented. Recombinant wild-type nNOS was found to associate with phosphatidylserine (PS) or phosphatidic acid (PA) but not with phosphatidylethanolamine (PE) or phosphatidylcholine (PC), indicating that nNOS-phospholipid binding requires an electrostatic interaction. A synthetic peptide corresponding to residues 732-754 blocked the interaction of nNOS with PS. Furthermore, a purified fusion protein containing residues 724-755 interacted with PS in a competitive fashion with CaM. Inactive nNOS lacking CaM-binding ability, generated by mutation of (Lys732LysLeu) to (Asp732AspGlu) (Watanabe, Y., Hu, Y., and Hidaka, H., FEBS Lett. 403, 75-78, 1997) did not interact with PS. Preincubation of nNOS with PS protected subsequent limited proteolysis of the synthase by Staphylococcus aureus V8 protease, probably as a result of conformational changes in the protein. Wild-type nNOS was found almost entirely in the membrane fraction of Sf9 cells, whereas inactive nNOS was also found in cytosolic fraction in Sf9 cells expressing the mutant enzyme. These results demonstrate that the mutated hydrophobic/basic amino acid cluster in nNOS sequence, Lys732LysLeu, is essential for nNOS-PS and nNOS-CaM interactions.

Amino Acid Sequence↗